Results for tag: "Femtosecond Laser Cataract Surgery"

Femtosecond laser cataract surgery is an advanced technology within the ophthalmic medical devices market that is used for the treatment of cataracts—a clouding of the eye's natural lens which can lead to a decrease in vision. The technology utilizes ultra-short bursts of laser energy to make incisions and fragment the cataract, allowing for a less invasive procedure compared to traditional manual techniques. It offers greater precision, reproducibility, and safety in the creation of the corneal incision, capsulotomy, and lens fragmentation. The market for this surgery is driven by an aging population, rising prevalence of cataracts, and patient demand for less invasive surgeries with faster recovery times. The incorporation of femtosecond laser technology in cataract surgery has been accompanied by developments in surgical techniques and customization of treatment, catering to the unique anatomical considerations of patients' eyes. Medical device regulatory bodies oversee the approval and usage of these lasers, ensuring they meet safety and efficacy standards. Companies operating in the femtosecond laser cataract surgery market include Alcon, part of Novartis International AG, which offers the LenSx laser, a widely used system for precision cataract surgery. Bausch + Lomb, another key player, provides the Victus Femtosecond Laser Platform. Zeiss Meditec AG is known for its VisuMax Femtosecond Laser, and Johnson & Johnson operates in this space through its subsidiary Abbott Show Less Read more